Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
15,781,393
-
Share change
-
+15,781,393
-
Total reported value
-
$426,251,845
-
Price per share
-
$27.01
-
Number of holders
-
47
-
Value change
-
+$426,251,845
-
Number of buys
-
47
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2020
As of 30 Jun 2020 Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) had 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,781,393 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Casdin Capital, LLC, CANADA PENSION PLAN INVESTMENT BOARD, PRICE T ROWE ASSOCIATES INC /MD/, BAILLIE GIFFORD & CO, Hudson Bay Capital Management LP, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, and FMR LLC.
This table shows 47 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.